Previous close | 146.10 |
Open | 146.25 |
Bid | 146.80 x 0 |
Ask | 147.05 x 0 |
Day's range | 146.25 - 146.25 |
52-week range | 113.00 - 149.60 |
Volume | |
Avg. volume | 8 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The United Kingdom's financial markets are currently poised at a critical juncture, with the FTSE 100's movements closely tied to the upcoming release of May's inflation data and decisions from the Bank of England. Amid these market conditions, identifying undervalued stocks can offer investors potential opportunities for growth in a fluctuating economic environment.
Viewing insider transactions for AstraZeneca PLC's ( LON:AZN ) over the last year, we see that insiders were net...
AstraZeneca is beginning to see momentum behind its oncology portfolio. CFO Aradhana Sarin says the work is only just beginning.